ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Why ANI should have a be given >$100 price target.

If you look at the explanation for Roth's Scott Henry lowering IGI Labs (Now TLGT) target price, you see that he assessed it at 7X the following year's (2016) revenue.

Insight in to how Scott Henry assess future value

October 28,2016 Roth reiterated TLGT's PT to $10

Using his previous formula that equals 5.85X revenue for 2017.

TLGT Analyst estimates

Even at 5.85X revenue ANIP's TP should be $90

ANIP Analyst estimates

However, ANIP is projected to approx. double TLGT 's revenue and produce earnings 6 times that of TLGT for in 2017. Which should give it a greater PPS/Revenue ratio.

Given the favorable treatment of biotechs and pharma following Trumps win. This should only elevate the valuations.

Hopefully, soon analyst will be able to realistically value ANIP.